• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义阴茎硬结症腔内维拉帕米注射治疗反应的预测因素。

Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.

机构信息

Sexual and Reproductive Medicine Program, Urology Service, Department of Surgery, Department of Psychiatry and Behavioral Services, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

BJU Int. 2011 Nov;108(9):1485-9. doi: 10.1111/j.1464-410X.2010.10029.x. Epub 2011 Jul 6.

DOI:10.1111/j.1464-410X.2010.10029.x
PMID:21733073
Abstract

OBJECTIVE

• To assess factors that predict penile curvature responses to intralesional verapamil (ILV) injection therapy for men with Peyronie's disease (PD).

PATIENTS AND METHODS

• Men with PD for <1 year were assessed at baseline and after 3 months of bi-monthly ILV-injection therapy. Curvature was assessed at the time of maximum penile rigidity. • Univariate relationships were tested with correlation or chi-square analyses. • Multivariate analyses included logistic and linear regression. • We analysed curvature improvement, defined as a decrease of ≥10 ° from baseline. Additionally, the relationship between curvature outcomes and patient age and degree of baseline penile curvature were assessed.

RESULTS

• Data from 131 men were included and the rates of penile curvature change were:26% improved, 12% worsened, and 62% stable. • Age (r=-0.24, P < 0.01) and larger baseline penile curvature (r= 0.33, P < 0.01) were associated with improved curvature on univariate analysis. • On multivariate analysis (logistic regression), both age [odds ratio (OR) 0.93, P < 0.01, 95%CI 0.89-0.97] and larger baseline penile curvature (OR 1.07, P < 0.01, 95%CI 1.04-1.11) were associated with improvements in curvature after ILV-injection therapy. • Improvements in curvature were associated with age (≤40 years vs >40 years; OR 0.27, P < 0.05, 95%CI 0.10-0.75) and degree of penile curvature at baseline (≤30 ° vs >30 °; OR 9.12, P < 0.01, 95%CI 1.94-42.84) when dichotomized as indicated.

CONCLUSION

• Younger age and larger baseline penile curvature were predictive of favourable curvature outcomes. • Analysis of dichotomized variables suggests that age and baseline curvature thresholds may be important to consider when deciding on ILV as a therapeutic strategy for PD.

摘要

目的

评估预测阴茎弯曲对接受腔内维拉帕米(ILV)注射治疗的男性的阴茎弯曲反应的因素。

患者和方法

对患有 PD 不到 1 年的男性在基线和每两个月接受 3 个月的 ILV 注射治疗后进行评估。在最大阴茎硬度时评估弯曲度。

用相关或卡方分析测试单变量关系。

多变量分析包括逻辑和线性回归。

我们分析了曲率改善,定义为与基线相比减少≥10°。此外,还评估了曲率结果与患者年龄和基线阴茎曲率程度之间的关系。

结果

纳入了 131 名男性的数据,阴茎弯曲变化率为:26%改善,12%恶化,62%稳定。

年龄(r=-0.24,P<0.01)和更大的基线阴茎曲率(r=0.33,P<0.01)在单变量分析中与曲率改善相关。

多变量分析(逻辑回归)显示,年龄[优势比(OR)0.93,P<0.01,95%CI 0.89-0.97]和更大的基线阴茎曲率(OR 1.07,P<0.01,95%CI 1.04-1.11)均与 ILV 注射治疗后曲率的改善相关。

曲率的改善与年龄(≤40 岁与>40 岁;OR 0.27,P<0.05,95%CI 0.10-0.75)和基线阴茎曲率程度(≤30°与>30°;OR 9.12,P<0.01,95%CI 1.94-42.84)相关,当以二分法表示时。

结论

年龄较小和更大的基线阴茎曲率是预测有利的曲率结果的因素。对二分变量的分析表明,年龄和基线曲率阈值可能在决定 ILV 作为 PD 的治疗策略时很重要。

相似文献

1
Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.定义阴茎硬结症腔内维拉帕米注射治疗反应的预测因素。
BJU Int. 2011 Nov;108(9):1485-9. doi: 10.1111/j.1464-410X.2010.10029.x. Epub 2011 Jul 6.
2
Intralesional verapamil prevents the progression of Peyronie's disease.病灶内注射维拉帕米可阻止佩罗尼氏病的进展。
Urology. 2007 Jun;69(6):1181-4. doi: 10.1016/j.urology.2007.02.042.
3
Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.三种不同维拉帕米稀释液用于佩罗尼氏病斑块内治疗的疗效和安全性的开放性初步随机前瞻性临床试验。
Urology. 2007 May;69(5):950-4. doi: 10.1016/j.urology.2007.01.080.
4
Treatment of Peyronie's disease with intralesional verapamil injection.病灶内注射维拉帕米治疗佩罗尼氏病。
J Urol. 1997 Oct;158(4):1395-9.
5
Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.局部应用前列环素类似物伊洛前列素治疗 Peyronie 病患者的安全性和耐受性:I 期研究。
BJU Int. 2012 Jul;110(1):117-21. doi: 10.1111/j.1464-410X.2011.10733.x. Epub 2011 Dec 16.
6
Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.与维拉帕米相比,病灶内注射透明质酸治疗佩罗尼氏病的评估:一项前瞻性、双盲、随机研究的初步结果
Andrology. 2017 Jul;5(4):771-775. doi: 10.1111/andr.12368.
7
Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.阴茎牵引、病灶内维拉帕米注射和口服治疗联合用于治疗 Peyronie 病。
J Sex Med. 2012 Jan;9(1):288-95. doi: 10.1111/j.1743-6109.2011.02519.x. Epub 2011 Oct 24.
8
Intralesional verapamil for the treatment of Peyronie's disease: a review.病灶内注射维拉帕米治疗佩罗尼氏病:综述
Int J Impot Res. 2002 Oct;14(5):324-8. doi: 10.1038/sj.ijir.3900917.
9
Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.病灶内注射干扰素-α2b可改善佩罗尼氏病男性患者的阴茎弯曲,与斑块位置无关。
J Urol. 2015 Dec;194(6):1704-7. doi: 10.1016/j.juro.2015.06.096. Epub 2015 Jul 3.
10
Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.维拉帕米与生理盐水用于佩罗尼氏病的电动力药物给药:一项双盲、安慰剂对照试验。
J Urol. 2007 Mar;177(3):972-5. doi: 10.1016/j.juro.2006.10.065.

引用本文的文献

1
Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study.佩罗尼氏病的体外冲击波疗法:一项单臂观察性研究的临床疗效与安全性
World J Mens Health. 2019 Sep;37(3):339-346. doi: 10.5534/wjmh.180100. Epub 2019 Mar 26.
2
Non-invasive treatment in the management of Peyronie's disease.佩罗尼氏病管理中的非侵入性治疗。
Ther Adv Urol. 2019 Feb 11;11:1756287218823671. doi: 10.1177/1756287218823671. eCollection 2019 Jan-Dec.
3
2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.
2018年加拿大泌尿外科协会佩罗尼氏病和先天性阴茎弯曲指南。
Can Urol Assoc J. 2018 May;12(5):E197-E209. doi: 10.5489/cuaj.5255. Epub 2018 Feb 22.
4
Lengthening strategies for Peyronie's disease.佩罗尼氏病的延长策略。
Transl Androl Urol. 2016 Jun;5(3):351-62. doi: 10.21037/tau.2016.04.03.
5
Peyronie's disease: What's around the bend?佩罗尼氏病:未来会怎样?
Indian J Urol. 2016 Jan-Mar;32(1):6-14. doi: 10.4103/0970-1591.173107.
6
PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.佩罗尼氏病:病因、诊断与治疗综述
Curr Sex Health Rep. 2015 Jun 1;7(2):117-131. doi: 10.1007/s11930-015-0045-y.
7
Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease.他达拉非每日一次联合病灶内维拉帕米注射:佩罗尼氏病的新治疗方向。
Urol Ann. 2015 Jul-Sep;7(3):345-9. doi: 10.4103/0974-7796.152048.
8
The non-surgical treatment of peyronie disease: 2013 update.佩罗尼氏病的非手术治疗:2013年更新版
World J Mens Health. 2013 Dec;31(3):183-92. doi: 10.5534/wjmh.2013.31.3.183. Epub 2013 Dec 24.